Jazz Pharmaceuticals has become the first drugmaker to get FDA approval for a treatment for diffuse midline glioma with H3 K27M mutations, a rare brain cancer mainly affecting young people. The ...
The FDA has approved Boehringer Ingelheim's nerandomilast as a treatment for idiopathic pulmonary fibrosis (IPF), giving the company a successor to its blockbuster therapy Ofev. Phosphodiesterase (PDE ...
Determining whether Hon Hai Precision Industry Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess ...
AI Nvidia to Make AI Supercomputers in Texas and Plans Up to $500 Billion in U.S. AI Production Go to the homepage.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback